| |
|
|---|
| 成交價 | 昨收 | 漲跌價 | 漲跌幅 | 振幅 | 開盤 | 最高 | 最低 | | 100 | 102 | -2 | -1.96% | 4.41% | 102.5 | 104.5 | 100 | | 成交張數 | 成交金額 | 成交筆數 | 成交均張 | 成交均價 | PBR | PER | PEG | | 1,245 | 1.27億 | 1,541 | 0.8張/筆 | 101.7元 | 1.59 | 95.24 | -1.38 | | 昨日張數 | 昨日金額 | 昨日筆數 | 昨日均張 | 昨日均價 | 昨漲跌價 (幅) | | 1,058 | 1.07億 | 1,512 | 0.7張/筆 | 101.6元 | +1 (+0.99%) | 連漲連跌: 連2漲→跌 ( -2元 / -1.96%)
財報評分: 最新45分 / 平均47分 上市指數: 19857.42 (-274.32 / -1.36%) | | | |
* 自2013年1月實施IFRSs後, 各項產品之單月營收已改為各公司自願申報, 若有無資料之情形, 即為該公司無申報產品營收, 請使用人多加留意。 | | |
| 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2024/03 | 111 | 107.5 | 117 | 96.8 | -2.5 | -2.27 | (1) | 膽固醇磷酸鹽結合劑 | 1.37 | 24.4 | +107.4 | +0.11 | 3.39 | 29.9 | -2.79 | | (2) | 維他命D衍生物 | 0.842 | 15 | +148.5 | -9.68 | 2 | 17.6 | -1.9 | | (3) | 呼吸系統用藥 | 0.651 | 11.5 | +22.9 | +62.4 | 1.58 | 14 | +56.3 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.499 | 8.85 | -1.25 | +27.2 | 1.36 | 12 | +15 | | (5) | 消炎止痛劑 | 0.294 | 5.22 | +336.6 | +358.4 | 0.369 | 3.25 | -10.5 | | (6) | 免疫調節劑 | 0.274 | 4.87 | +4411.3 | +363.5 | 0.367 | 3.23 | +286.9 | | (7) | 抗癌活性成份 | 0.189 | 3.35 | -51.6 | -42.6 | 0.841 | 7.41 | +24.2 | | (8) | 中樞神經系統用藥 | 0.0016 | 0.03 | - | -76.2 | - | - | - | | 其他 | 其他 | 1.57 | 27.9 | +7861.8 | +423.3 | 1.65 | 14.6 | +292.6 | | 減 | 銷貨退回及折讓 | 0.0622 | -1.1 | 0 | - | 0.242 | -2.14 | +3098.9 | | 合計 | 業務營收淨額 | 5.63 | 100 | +129.3 | +46.1 | 11.34 | 100 | +21.7 | | 2024/02 | 112.5 | 110 | 114.5 | 102 | -2.5 | -2.22 | (1) | 膽固醇磷酸鹽結合劑 | 0.662 | 26.9 | -51 | -38.2 | 2.01 | 35.3 | -4.67 | | (2) | 呼吸系統用藥 | 0.529 | 21.5 | +30.8 | +21.8 | 0.934 | 16.4 | +52.4 | | (3) | 委託研發代工生產(CDMO/勞務) | 0.505 | 20.6 | +42.8 | -15.2 | 0.859 | 15 | +8.97 | | (4) | 抗癌活性成份 | 0.39 | 15.9 | +49.5 | +54.4 | 0.652 | 11.4 | +87.3 | | (5) | 維他命D衍生物 | 0.339 | 13.8 | -58.5 | +31.1 | 1.16 | 20.3 | +4.66 | | (6) | 消炎止痛劑 | 0.0674 | 2.74 | +813.1 | +57.3 | 0.0748 | 1.31 | -78.5 | | (7) | 免疫調節劑 | 0.0061 | 0.25 | -92.9 | -56.6 | 0.0923 | 1.62 | +159.5 | | 其他 | 其他 | 0.0197 | 0.8 | -67.4 | -81.6 | 0.0802 | 1.41 | -33.4 | | 減 | 銷貨退回及折讓 | 0.0622 | -2.53 | -47.2 | +722.4 | 0.18 | -3.15 | +2277.7 | | 合計 | 業務營收淨額 | 2.46 | 100 | -24.4 | -11.3 | 5.71 | 100 | +4.48 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2024/01 | 103 | 112.5 | 121 | 98.1 | +10.5 | +10.29 | (1) | 膽固醇磷酸鹽結合劑 | 1.35 | 41.6 | -28.7 | +29.9 | 1.35 | 41.6 | +29.9 | | (2) | 維他命D衍生物 | 0.818 | 25.2 | +1.86 | -3.42 | 0.818 | 25.2 | -3.42 | | (3) | 呼吸系統用藥 | 0.405 | 12.4 | -16.4 | +127 | 0.405 | 12.4 | +127 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.354 | 10.9 | -32.3 | +83.7 | 0.354 | 10.9 | +83.7 | | (5) | 抗癌活性成份 | 0.261 | 8.03 | -34.2 | +174.9 | 0.261 | 8.03 | +174.9 | | (6) | 免疫調節劑 | 0.0862 | 2.65 | -27.4 | +300.2 | 0.0862 | 2.65 | +300.2 | | (7) | 中樞神經系統用藥 | 0.0254 | 0.78 | -94.4 | - | 0.0254 | 0.78 | - | | (8) | 消炎止痛劑 | 0.0074 | 0.23 | -98.2 | -97.6 | 0.0074 | 0.23 | -97.6 | | 其他 | 其他 | 0.0605 | 1.86 | +171.3 | +353.4 | 0.0605 | 1.86 | +353.4 | | 減 | 銷貨退回及折讓 | 0.118 | -3.62 | -32.8 | - | 0.118 | -3.62 | - | | 合計 | 業務營收淨額 | 3.25 | 100 | -34.2 | +20.7 | 3.25 | 100 | +20.7 | | 2023/12 | 99.8 | 102 | 108 | 95 | +2 | +2 | (1) | 膽固醇磷酸鹽結合劑 | 1.9 | 38.4 | +50.3 | +113.3 | 15.84 | 36.3 | +19.1 | | (2) | 維他命D衍生物 | 0.803 | 16.2 | +229.3 | +2.74 | 8.09 | 18.6 | +14.6 | | (3) | 委託研發代工生產(CDMO/勞務) | 0.522 | 10.6 | +67.4 | - | 5.29 | 12.1 | - | | (4) | 呼吸系統用藥 | 0.484 | 9.79 | +36.3 | +20.3 | 4.82 | 11 | +34.8 | | (5) | 中樞神經系統用藥 | 0.457 | 9.24 | -7.85 | +15.2 | - | - | - | | (6) | 消炎止痛劑 | 0.418 | 8.46 | +94.9 | +19260.2 | 2.08 | 4.78 | - | | (7) | 抗癌活性成份 | 0.397 | 8.03 | +110.4 | +271.1 | 2.6 | 5.95 | +121.2 | | (8) | 免疫調節劑 | 0.119 | 2.4 | +1170.6 | -20.8 | - | - | - | | 其他 | 其他 | 0.0223 | 0.45 | -69.2 | -88.3 | 2.54 | 5.81 | - | | 減 | 銷貨退回及折讓 | 0.175 | -3.54 | - | - | 0.277 | -0.64 | +340.2 | | 合計 | 業務營收淨額 | 4.94 | 100 | +56.8 | +32.4 | 43.6 | 100 | +15.8 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/11 | 86.8 | 100 | 105.5 | 78 | +14.1 | +16.41 | (1) | 膽固醇磷酸鹽結合劑 | 1.26 | 40 | -7.72 | -0.42 | 13.94 | 36.1 | +12.3 | | (2) | 中樞神經系統用藥 | 0.496 | 15.7 | - | +2507.9 | - | - | - | | (3) | 呼吸系統用藥 | 0.355 | 11.3 | -26.6 | +31.3 | 4.33 | 11.2 | +36.6 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.312 | 9.89 | -30.2 | - | 4.77 | 12.3 | - | | (5) | 維他命D衍生物 | 0.244 | 7.73 | -74.1 | -63.8 | 7.29 | 18.9 | +16.1 | | (6) | 消炎止痛劑 | 0.215 | 6.8 | -51 | -21.4 | 1.67 | 4.31 | - | | (7) | 抗癌活性成份 | 0.189 | 5.98 | -41.5 | +138.9 | 2.2 | 5.69 | +106.2 | | (8) | 免疫調節劑 | 0.0093 | 0.3 | -17.9 | -88.6 | - | - | - | | 其他 | 其他 | 0.0723 | 2.29 | +63.8 | - | 2.51 | 6.5 | - | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0.102 | -0.26 | +61.8 | | 合計 | 業務營收淨額 | 3.15 | 100 | -21.7 | -7.73 | 38.66 | 100 | +14 | | 2023/10 | 88.4 | 85.9 | 90.1 | 78.1 | -1.8 | -2.05 | (1) | 膽固醇磷酸鹽結合劑 | 1.37 | 34 | -1.05 | +17.8 | 12.68 | 35.7 | +13.8 | | (2) | 維他命D衍生物 | 0.943 | 23.4 | +321.3 | +30.6 | 7.04 | 19.8 | +25.7 | | (3) | 呼吸系統用藥 | 0.484 | 12 | +9.88 | +17.7 | 3.98 | 11.2 | +37.1 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.447 | 11.1 | +3.11 | - | 4.46 | 12.6 | - | | (5) | 消炎止痛劑 | 0.438 | 10.9 | +38.4 | - | 1.45 | 4.09 | - | | (6) | 抗癌活性成份 | 0.322 | 8.01 | +13.7 | +1681.6 | 2.01 | 5.66 | +103.6 | | (7) | 免疫調節劑 | 0.0114 | 0.28 | -84.2 | -91.2 | - | - | - | | 其他 | 其他 | 0.0441 | 1.1 | -79.6 | -59.3 | 2.44 | 6.87 | +152.5 | | 減 | 銷貨退回及折讓 | 0.0311 | -0.77 | +103500 | - | 0.102 | -0.29 | +93 | | 合計 | 業務營收淨額 | 4.03 | 100 | +4.51 | +14 | 35.51 | 100 | +16.4 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/09 | 86.3 | 87.7 | 95.5 | 84.7 | +1.9 | +2.21 | (1) | 膽固醇磷酸鹽結合劑 | 1.38 | 35.9 | +7.18 | -7.18 | 11.31 | 35.9 | +13.3 | | (2) | 中樞神經系統用藥 | 0.484 | 12.6 | +8814.7 | - | - | - | - | | (3) | 呼吸系統用藥 | 0.44 | 11.4 | +2.95 | -8.91 | 3.49 | 11.1 | +40.3 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.433 | 11.3 | -45.5 | - | 4.01 | 12.7 | - | | (5) | 消炎止痛劑 | 0.316 | 8.21 | +253.7 | +86.3 | 1.01 | 3.22 | -58.6 | | (6) | 抗癌活性成份 | 0.284 | 7.36 | +18.9 | +31.1 | 1.69 | 5.36 | +74.1 | | (7) | 維他命D衍生物 | 0.224 | 5.81 | -75.3 | -55.8 | 6.1 | 19.4 | +24.9 | | (8) | 免疫調節劑 | 0.072 | 1.87 | +163.2 | -71.6 | - | - | - | | 其他 | 其他 | 0.216 | 5.61 | -22 | +78.7 | 2.4 | 7.61 | +179.3 | | 減 | 銷貨退回及折讓 | 0 | 0 | -99.9 | -99.6 | 0.0708 | -0.22 | +34.1 | | 合計 | 業務營收淨額 | 3.85 | 100 | -4.03 | -4.84 | 31.48 | 100 | +16.7 | | 2023/08 | 104 | 85.8 | 121 | 81.6 | -15.7 | -15.47 | (1) | 膽固醇磷酸鹽結合劑 | 1.29 | 32.1 | -9.06 | +45.8 | 9.93 | 35.9 | +16.9 | | (2) | 維他命D衍生物 | 0.905 | 22.5 | +50.6 | +22 | 5.88 | 21.3 | +34.3 | | (3) | 委託研發代工生產(CDMO/勞務) | 0.795 | 19.8 | +42.2 | - | 3.58 | 13 | - | | (4) | 呼吸系統用藥 | 0.428 | 10.7 | -23.2 | +13.6 | 3.05 | 11.1 | +52.2 | | (5) | 抗癌活性成份 | 0.239 | 5.94 | +1249.4 | +21.7 | 1.4 | 5.08 | +86.5 | | (6) | 消炎止痛劑 | 0.0894 | 2.23 | +3.03 | +272.4 | 0.697 | 2.52 | -69.4 | | (7) | 免疫調節劑 | 0.0274 | 0.68 | - | -79 | - | - | - | | (8) | 中樞神經系統用藥 | 0.0054 | 0.14 | - | +44.4 | - | - | - | | 其他 | 其他 | 0.277 | 6.9 | +34.1 | +805.1 | 2.18 | 7.89 | +195.8 | | 減 | 銷貨退回及折讓 | 0.0414 | -1.03 | +104.3 | - | 0.0707 | -0.26 | +55.2 | | 合計 | 業務營收淨額 | 4.01 | 100 | +17.2 | +43.8 | 27.63 | 100 | +20.5 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/07 | 92.8 | 101.5 | 109.5 | 88.3 | +9.1 | +9.85 | (1) | 膽固醇磷酸鹽結合劑 | 1.42 | 41.4 | +16.1 | +32.5 | 8.64 | 36.6 | +13.6 | | (2) | 維他命D衍生物 | 0.601 | 17.5 | -35.3 | +52.1 | 4.97 | 21.1 | +36.8 | | (3) | 委託研發代工生產(CDMO/勞務) | 0.559 | 16.3 | +34.1 | - | 2.78 | 11.8 | - | | (4) | 呼吸系統用藥 | 0.557 | 16.3 | +77.2 | -9.47 | 2.63 | 11.1 | +61.2 | | (5) | 消炎止痛劑 | 0.0868 | 2.53 | +132.9 | -82.1 | 0.607 | 2.57 | -73.1 | | (6) | 抗癌活性成份 | 0.0177 | 0.52 | -95 | -48.2 | 1.17 | 4.94 | +109.3 | | 其他 | 其他 | 0.207 | 6.03 | -60 | +205.8 | 1.9 | 8.06 | +169.4 | | 減 | 銷貨退回及折讓 | 0.0202 | -0.59 | +1231.6 | - | 0.0294 | -0.12 | -35.5 | | 合計 | 業務營收淨額 | 3.43 | 100 | -23 | +0.71 | 23.62 | 100 | +17.3 | | 2023/06 | 85.6 | 92.4 | 103 | 82.6 | +6.8 | +7.94 | (1) | 膽固醇磷酸鹽結合劑 | 1.22 | 27.5 | -4.26 | -5.02 | 7.22 | 35.8 | +10.5 | | (2) | 維他命D衍生物 | 0.929 | 20.9 | +19.5 | +112.7 | 4.37 | 21.7 | +34.9 | | (3) | 中樞神經系統用藥 | 0.417 | 9.38 | +806.3 | +887.1 | - | - | - | | (4) | 委託研發代工生產(CDMO/勞務) | 0.417 | 9.37 | +59.1 | - | 2.23 | 11 | - | | (5) | 抗癌活性成份 | 0.351 | 7.9 | +1654.7 | +135015.4 | 1.15 | 5.69 | +119.6 | | (6) | 呼吸系統用藥 | 0.314 | 7.07 | -25.3 | +30.7 | 2.07 | 10.2 | +104 | | (7) | 免疫調節劑 | 0.247 | 5.54 | +192.1 | +61 | 0.45 | 2.23 | - | | (8) | 消炎止痛劑 | 0.0373 | 0.84 | +342.1 | -75.7 | 0.52 | 2.58 | -70.6 | | 其他 | 其他 | 0.516 | 11.6 | +27.8 | +818.8 | 1.7 | 8.4 | +165.5 | | 減 | 銷貨退回及折讓 | 0.0015 | -0.03 | - | -96.3 | 0.0092 | -0.05 | -79.9 | | 合計 | 業務營收淨額 | 4.45 | 100 | +34.9 | +43.3 | 20.19 | 100 | +20.7 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/05 | 87.7 | 85.6 | 100 | 82.2 | +2.4 | +2.88 | (1) | 膽固醇磷酸鹽結合劑 | 1.28 | 38.7 | +3.12 | +10.9 | 6 | 38.1 | +14.3 | | (2) | 維他命D衍生物 | 0.777 | 23.6 | +23.5 | +189.5 | 3.44 | 21.9 | +22.8 | | (3) | 呼吸系統用藥 | 0.421 | 12.8 | +31.8 | +127 | 1.75 | 11.1 | +126.9 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.262 | 7.94 | -28.5 | - | 1.81 | 11.5 | - | | (5) | 免疫調節劑 | 0.0844 | 2.56 | +249.1 | +548.4 | 0.203 | 1.29 | - | | (6) | 中樞神經系統用藥 | 0.0461 | 1.4 | +73.6 | +121.5 | - | - | - | | (7) | 抗癌活性成份 | 0.02 | 0.61 | -80.1 | -81.8 | 0.797 | 5.07 | +52.5 | | (8) | 消炎止痛劑 | 0.0084 | 0.26 | -86.5 | -87.9 | 0.483 | 3.07 | -70.1 | | 其他 | 其他 | 0.404 | 12.2 | +13.6 | +132.5 | 1.18 | 7.5 | +102.5 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0.0076 | -0.05 | +67.5 | | 合計 | 業務營收淨額 | 3.3 | 100 | +5.67 | +37.7 | 15.74 | 100 | +15.5 | | 2023/04 | 76.8 | 83.2 | 88.6 | 76.7 | +6.5 | +8.47 | (1) | 膽固醇磷酸鹽結合劑 | 1.24 | 39.6 | -9.8 | +23.6 | 4.72 | 37.9 | +15.2 | | (2) | 維他命D衍生物 | 0.629 | 20.2 | -32.5 | +5.33 | 2.67 | 21.4 | +5.17 | | (3) | 委託研發代工生產(CDMO/勞務) | 0.367 | 11.7 | -6.57 | - | 1.55 | 12.4 | - | | (4) | 呼吸系統用藥 | 0.319 | 10.2 | -20.3 | +106.7 | 1.33 | 10.7 | +126.8 | | (5) | 抗癌活性成份 | 0.1 | 3.22 | -69.5 | +55.2 | 0.777 | 6.25 | +88.3 | | (6) | 消炎止痛劑 | 0.0625 | 2 | -2.6 | -87.6 | 0.475 | 3.82 | -69.3 | | (7) | 中樞神經系統用藥 | 0.0265 | 0.85 | +297.2 | -90.8 | - | - | - | | (8) | 免疫調節劑 | 0.0242 | 0.77 | -59.1 | -0.98 | 0.119 | 0.96 | - | | 其他 | 其他 | 0.356 | 11.4 | +18.4 | +282.1 | 0.776 | 6.24 | +89.8 | | 減 | 銷貨退回及折讓 | 0.0001 | 0 | - | - | 0.0076 | -0.06 | +67.5 | | 合計 | 業務營收淨額 | 3.12 | 100 | -19.1 | +8.25 | 12.44 | 100 | +10.8 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/03 | 72.5 | 76.7 | 78.3 | 66.5 | +4.8 | +6.68 | (1) | 膽固醇磷酸鹽結合劑 | 1.37 | 35.6 | +27.9 | +14.4 | 3.48 | 37.4 | +12.5 | | (2) | 維他命D衍生物 | 0.933 | 24.2 | +260.7 | +64.7 | 2.04 | 21.9 | +5.12 | | (3) | 呼吸系統用藥 | 0.401 | 10.4 | -7.75 | +832.6 | 1.01 | 10.9 | +134 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.392 | 10.2 | -34.1 | - | 1.18 | 12.7 | - | | (5) | 抗癌活性成份 | 0.329 | 8.53 | +30.1 | +34.1 | 0.677 | 7.26 | +94.4 | | (6) | 消炎止痛劑 | 0.0642 | 1.66 | +49.8 | -87.6 | 0.412 | 4.42 | -60.5 | | (7) | 免疫調節劑 | 0.0592 | 1.53 | +322.1 | - | 0.0947 | 1.02 | - | | (8) | 中樞神經系統用藥 | 0.0067 | 0.17 | - | -95.2 | - | - | - | | 其他 | 其他 | 0.3 | 7.79 | +180.5 | +10.9 | 0.421 | 4.51 | +33.2 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0.0076 | -0.08 | +66 | | 合計 | 業務營收淨額 | 3.86 | 100 | +39.2 | +12.7 | 9.32 | 100 | +11.6 | | 2023/02 | 65.3 | 71.9 | 73.3 | 64.4 | +7 | +10.79 | (1) | 膽固醇磷酸鹽結合劑 | 1.07 | 38.7 | +3.03 | +11.7 | 2.11 | 38.7 | +11.3 | | (2) | 委託研發代工生產(CDMO/勞務) | 0.596 | 21.5 | +209.2 | - | 0.788 | 14.4 | - | | (3) | 呼吸系統用藥 | 0.434 | 15.7 | +143.7 | +129.1 | 0.613 | 11.2 | +57 | | (4) | 維他命D衍生物 | 0.259 | 9.34 | -69.5 | +18.1 | 1.11 | 20.2 | -19.5 | | (5) | 抗癌活性成份 | 0.253 | 9.13 | +166.1 | +412.6 | 0.348 | 6.37 | +238.3 | | (6) | 消炎止痛劑 | 0.0428 | 1.55 | -86 | -84.9 | 0.348 | 6.37 | -34.2 | | (7) | 免疫調節劑 | 0.014 | 0.51 | -34.9 | -70.4 | 0.0356 | 0.65 | -28.3 | | 其他 | 其他 | 0.107 | 3.87 | +702.7 | +2168.6 | 0.12 | 2.2 | +166.4 | | 減 | 銷貨退回及折讓 | 0.0076 | -0.27 | +75500 | +65.8 | 0.0076 | -0.14 | +66 | | 合計 | 業務營收淨額 | 2.77 | 100 | +2.85 | +34.1 | 5.46 | 100 | +10.9 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2023/01 | 72.4 | 64.9 | 72.9 | 62.6 | -8.6 | -11.7 | (1) | 膽固醇磷酸鹽結合劑 | 1.04 | 38.6 | +17 | +10.9 | 1.04 | 38.6 | +10.9 | | (2) | 維他命D衍生物 | 0.847 | 31.4 | +8.36 | -26.6 | 0.847 | 31.4 | -26.6 | | (3) | 消炎止痛劑 | 0.305 | 11.3 | +14032.4 | +24.7 | 0.305 | 11.3 | +24.7 | | (4) | 委託研發代工生產(CDMO/勞務) | 0.193 | 7.15 | - | - | 0.193 | 7.15 | - | | (5) | 呼吸系統用藥 | 0.178 | 6.62 | -55.7 | -11.1 | 0.178 | 6.62 | -11.1 | | (6) | 抗癌活性成份 | 0.095 | 3.53 | -11.2 | +77.6 | 0.095 | 3.53 | +77.6 | | (7) | 免疫調節劑 | 0.0215 | 0.8 | -85.6 | +848.9 | 0.0215 | 0.8 | +848.9 | | 其他 | 其他 | 0.0133 | 0.5 | -93 | -67.1 | 0.0133 | 0.5 | -67.1 | | 減 | 銷貨退回及折讓 | 0 | 0 | 0 | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 2.69 | 100 | -27.9 | -5.85 | 2.69 | 100 | -5.85 | | 2022/12 | 60.9 | 73.5 | 81.6 | 59.2 | +13.3 | +22.09 | (1) | 膽固醇磷酸鹽結合劑 | 0.89 | 23.8 | -29.8 | -35.5 | 13.3 | 35.3 | +10 | | (2) | 委託研發代工生產(CDMO) | 0.815 | 21.8 | +120.8 | - | - | - | - | | (3) | 維他命D衍生物 | 0.781 | 20.9 | +16.1 | +66.8 | 7.06 | 18.8 | +16.4 | | (4) | 呼吸系統用藥 | 0.402 | 10.8 | +48.7 | +191.1 | 3.57 | 9.49 | +79.7 | | (5) | 中樞神經系統用藥 | 0.396 | 10.6 | +1985.3 | -21.6 | - | - | - | | (6) | 免疫調節劑 | 0.15 | 4.02 | +82.4 | +93 | - | - | - | | (7) | 抗癌活性成份 | 0.107 | 2.86 | +35.4 | +221.3 | 1.17 | 3.12 | +21 | | (8) | 消炎止痛劑 | 0.0022 | 0.06 | -99.2 | -99.1 | - | - | - | | 其他 | 其他 | 0.19 | 5.1 | - | -35.3 | - | - | - | | 減 | 銷貨退回及折讓 | 0 | 0 | -99.9 | -100 | 0.063 | -0.17 | -73.6 | | 合計 | 業務營收淨額 | 3.73 | 100 | +9.25 | +16.2 | 37.66 | 100 | +19.8 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/11 | 47.75 | 60.2 | 61.1 | 47.7 | +12.9 | +27.27 | (1) | 膽固醇磷酸鹽結合劑 | 1.27 | 37.1 | +9.17 | +39.1 | 12.41 | 36.6 | +15.9 | | (2) | 維他命D衍生物 | 0.673 | 19.7 | -6.76 | -18.1 | 6.28 | 18.5 | +12.2 | | (3) | 委託研發代工生產(CDMO) | 0.369 | 10.8 | -33.1 | - | - | - | - | | (4) | 紫外線吸收劑 | 0.35 | 10.2 | - | +417.4 | - | - | - | | (5) | 消炎止痛劑 | 0.273 | 7.99 | - | -1.11 | - | - | - | | (6) | 呼吸系統用藥 | 0.271 | 7.92 | -34.2 | -30.7 | 3.17 | 9.35 | +71.4 | | (7) | 免疫調節劑 | 0.0822 | 2.41 | -36.4 | +15.6 | - | - | - | | (8) | 抗癌活性成份 | 0.079 | 2.31 | +336.5 | +1864.2 | 1.07 | 3.14 | +13.8 | | (9) | 勞務 | 0.0445 | 1.3 | +179.6 | -43.5 | - | - | - | | (10) | 中樞神經系統用藥 | 0.019 | 0.56 | -95.4 | -81.1 | - | - | - | | 減 | 銷貨退回及折讓 | 0.0102 | -0.3 | - | - | 0.0629 | -0.19 | -69.8 | | 合計 | 業務營收淨額 | 3.42 | 100 | -3.23 | +9.92 | 33.92 | 100 | +20.2 | | 2022/10 | 48.9 | 47.3 | 50.8 | 45.35 | -1.6 | -3.27 | (1) | 膽固醇磷酸鹽結合劑 | 1.16 | 32.9 | -22 | +17.4 | 11.14 | 36.5 | +13.7 | | (2) | 維他命D衍生物 | 0.722 | 20.4 | +42.6 | +54 | 5.61 | 18.4 | +17.4 | | (3) | 委託研發代工生產(CDMO) | 0.551 | 15.6 | +58 | - | - | - | - | | (4) | 中樞神經系統用藥 | 0.414 | 11.7 | - | +195.8 | - | - | - | | (5) | 呼吸系統用藥 | 0.411 | 11.6 | -15 | +35.1 | 2.9 | 9.51 | +98.7 | | (6) | 免疫調節劑 | 0.129 | 3.66 | -49.1 | -4.91 | - | - | - | | (7) | 抗癌活性成份 | 0.0181 | 0.51 | -91.6 | -69.4 | 0.988 | 3.24 | +5.87 | | (8) | 勞務 | 0.0159 | 0.45 | -96.6 | -70.1 | - | - | - | | 其他 | 其他 | 0.108 | 3.07 | -10.3 | -58.6 | 0.967 | 3.17 | -49.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0.0528 | -0.17 | -74.7 | | 合計 | 業務營收淨額 | 3.53 | 100 | -12.8 | +37.5 | 30.5 | 100 | +21.5 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/09 | 60.1 | 48.9 | 61.3 | 47 | -11 | -18.36 | (1) | 膽固醇磷酸鹽結合劑 | 1.49 | 36.8 | +68.3 | +26.6 | 9.98 | 37 | +13.3 | | (2) | 維他命D衍生物 | 0.506 | 12.5 | -31.8 | -35 | 4.88 | 18.1 | +13.4 | | (3) | 呼吸系統用藥 | 0.484 | 11.9 | +28.3 | +118.4 | 2.49 | 9.23 | +115.4 | | (4) | 勞務 | 0.466 | 11.5 | +4628.2 | +47.8 | - | - | - | | (5) | 委託研發代工生產(CDMO) | 0.349 | 8.62 | -11.2 | - | - | - | - | | (6) | 免疫調節劑 | 0.254 | 6.27 | +95.3 | - | - | - | - | | (7) | 抗癌活性成份 | 0.216 | 5.34 | +10.3 | -9.3 | 0.97 | 3.59 | +11 | | (8) | 消炎止痛劑 | 0.17 | 4.2 | +607.2 | +2927.8 | 2.45 | 9.08 | +42.9 | | 其他 | 其他 | 0.121 | 2.99 | +295.1 | +75.3 | 0.858 | 3.18 | -48.4 | | 減 | 銷貨退回及折讓 | 0.0072 | -0.18 | - | -96 | 0.0528 | -0.2 | -74.7 | | 合計 | 業務營收淨額 | 4.05 | 100 | +45.1 | +44.8 | 26.97 | 100 | +19.7 | | 2022/08 | 46.8 | 59.9 | 62.8 | 44.2 | +13.55 | +29.23 | (1) | 膽固醇磷酸鹽結合劑 | 0.885 | 31.7 | -17.3 | -27.3 | 8.49 | 37 | +11.3 | | (2) | 維他命D衍生物 | 0.742 | 26.6 | +87.8 | +149.4 | 4.38 | 19.1 | +24.1 | | (3) | 委託研發代工生產(CDMO) | 0.393 | 14.1 | +76.3 | - | - | - | - | | (4) | 呼吸系統用藥 | 0.377 | 13.5 | -38.8 | +1014.1 | 2.01 | 8.75 | +114.8 | | (5) | 抗癌活性成份 | 0.196 | 7.02 | +474.4 | +2410 | 0.753 | 3.29 | +18.6 | | (6) | 免疫調節劑 | 0.13 | 4.66 | +225.9 | -20.7 | - | - | - | | (7) | 消炎止痛劑 | 0.024 | 0.86 | -95 | -39.1 | 2.28 | 9.94 | +33.4 | | (8) | 勞務 | 0.0099 | 0.35 | - | -91 | - | - | - | | (9) | 中樞神經系統用藥 | 0.0038 | 0.13 | -99.2 | -83.2 | 1.15 | 5.02 | +215.7 | | 其他 | 其他 | 0.0306 | 1.1 | -54.7 | -60.2 | 0.737 | 3.22 | -53.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0.0456 | -0.2 | +65 | | 合計 | 業務營收淨額 | 2.79 | 100 | -18 | +31 | 22.92 | 100 | +16.1 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/07 | 50.5 | 46.35 | 50.6 | 46 | -4.15 | -8.22 | (1) | 膽固醇磷酸鹽結合劑 | 1.07 | 31.5 | -16.8 | +48.8 | 7.61 | 37.8 | +18.6 | | (2) | 呼吸系統用藥 | 0.615 | 18.1 | +155.8 | +931.7 | 1.63 | 8.09 | +81 | | (3) | 消炎止痛劑 | 0.484 | 14.2 | +215.1 | +127.9 | 2.26 | 11.2 | +35.2 | | (4) | 中樞神經系統用藥 | 0.472 | 13.9 | +1017 | +701.3 | 1.15 | 5.7 | +235.2 | | (5) | 維他命D衍生物 | 0.395 | 11.6 | -9.52 | -11.3 | 3.64 | 18.1 | +12.5 | | (6) | 委託研發代工生產(CDMO) | 0.223 | 6.55 | -71.3 | - | - | - | - | | (7) | 免疫調節劑 | 0.0399 | 1.17 | -74 | -83.4 | - | - | - | | (8) | 抗癌活性成份 | 0.0341 | 1 | +13026.9 | +529.7 | 0.557 | 2.77 | -11.2 | | 其他 | 其他 | 0.0676 | 1.99 | +20.3 | +270.2 | 0.707 | 3.51 | -53.4 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0.0456 | -0.23 | +65 | | 合計 | 業務營收淨額 | 3.4 | 100 | +9.61 | +77.5 | 20.13 | 100 | +14.3 | | 2022/06 | 49.05 | 50.5 | 52.3 | 48.1 | +1.45 | +2.96 | (1) | 膽固醇磷酸鹽結合劑 | 1.29 | 41.4 | +11.8 | +41.3 | 6.53 | 39.1 | +14.8 | | (2) | 委託研發代工生產(CDMO) | 0.776 | 25 | +101.1 | - | - | - | - | | (3) | 維他命D衍生物 | 0.437 | 14.1 | +62.6 | -20 | 3.24 | 19.4 | +16.4 | | (4) | 呼吸系統用藥 | 0.241 | 7.75 | +29.7 | +72793.9 | 1.01 | 6.06 | +20.6 | | (5) | 消炎止痛劑 | 0.154 | 4.95 | +120.1 | -0.64 | 1.77 | 10.6 | +21.6 | | (6) | 免疫調節劑 | 0.153 | 4.94 | +1076.7 | +43.8 | - | - | - | | (7) | 中樞神經系統用藥 | 0.0423 | 1.36 | +103.4 | +58 | 0.675 | 4.03 | +138.2 | | (8) | 抗癌活性成份 | 0.0003 | 0.01 | -99.8 | -99.5 | 0.523 | 3.13 | -15.9 | | 其他 | 其他 | 0.0562 | 1.81 | -67.7 | -92.2 | 0.639 | 3.82 | -57.4 | | 減 | 銷貨退回及折讓 | 0.041 | -1.32 | - | +2432.1 | 0.0456 | -0.27 | +74.7 | | 合計 | 業務營收淨額 | 3.1 | 100 | +29.6 | +8.33 | 16.73 | 100 | +6.63 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/05 | 64.1 | 49.05 | 64.5 | 47.6 | -14.85 | -23.24 | (1) | 膽固醇磷酸鹽結合劑 | 1.15 | 48 | +14.9 | +15.4 | 5.25 | 38.5 | +9.72 | | (2) | 委託研發代工生產(CDMO) | 0.386 | 16.1 | +475.2 | - | - | - | - | | (3) | 維他命D衍生物 | 0.268 | 11.2 | -55.1 | -29.7 | 2.8 | 20.6 | +25.2 | | (4) | 呼吸系統用藥 | 0.185 | 7.75 | +20 | +6230.7 | 0.773 | 5.67 | -7.99 | | (5) | 抗癌活性成份 | 0.11 | 4.6 | +70.1 | +56.2 | 0.523 | 3.84 | -8.41 | | (6) | 消炎止痛劑 | 0.0698 | 2.91 | -86.1 | -72.7 | 1.62 | 11.9 | +24.3 | | (7) | 中樞神經系統用藥 | 0.0208 | 0.87 | -92.8 | -79.5 | 0.633 | 4.64 | +146.6 | | (8) | 紫外線吸收劑 | 0.0176 | 0.73 | -79.5 | -90.2 | 0.702 | 5.15 | +0.79 | | (9) | 免疫調節劑 | 0.013 | 0.54 | -46.7 | - | - | - | - | | 其他 | 其他 | 0.174 | 7.26 | +86.7 | -41.6 | 0.583 | 4.28 | -25 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | -100 | 0.0046 | -0.03 | -81.4 | | 合計 | 業務營收淨額 | 2.39 | 100 | -17 | -4.79 | 13.63 | 100 | +6.25 | | 2022/04 | 56.7 | 63.9 | 70.9 | 56.3 | +7.1 | +12.5 | (1) | 膽固醇磷酸鹽結合劑 | 1 | 34.7 | -16.5 | -10.5 | 4.1 | 36.5 | +8.24 | | (2) | 維他命D衍生物 | 0.598 | 20.7 | +5.5 | -13.1 | 2.54 | 22.6 | +36.5 | | (3) | 消炎止痛劑 | 0.503 | 17.4 | -2.43 | +28.6 | 1.55 | 13.8 | +48 | | (4) | 中樞神經系統用藥 | 0.289 | 10 | +106.2 | +657.6 | 0.612 | 5.45 | +294.7 | | (5) | 呼吸系統用藥 | 0.155 | 5.36 | +259.6 | -29.7 | 0.588 | 5.23 | -29.8 | | (6) | 紫外線吸收劑 | 0.086 | 2.98 | -70.6 | -37.1 | 0.684 | 6.09 | +32.2 | | (7) | 委託研發代工生產(CDMO) | 0.0671 | 2.33 | - | - | - | - | - | | (8) | 抗癌活性成份 | 0.0647 | 2.24 | -73.6 | -8.63 | 0.413 | 3.67 | -17.5 | | (9) | 免疫調節劑 | 0.0244 | 0.85 | - | -64.7 | - | - | - | | (10) | 勞務 | 0.0034 | 0.12 | -97.8 | -97.9 | 0.209 | 1.86 | -54.9 | | 其他 | 其他 | 0.0931 | 3.23 | -65.6 | +48.8 | 0.409 | 3.64 | -14.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | -100 | 0.0046 | -0.04 | +11.8 | | 合計 | 業務營收淨額 | 2.88 | 100 | -15.8 | -2.2 | 11.23 | 100 | +8.94 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/03 | 57.3 | 56.8 | 58.7 | 54.3 | -0.3 | -0.53 | (1) | 膽固醇磷酸鹽結合劑 | 1.2 | 35 | +25 | +28.2 | 3.1 | 37.1 | +16.1 | | (2) | 維他命D衍生物 | 0.566 | 16.5 | +158.6 | +19.1 | 1.94 | 23.2 | +65.7 | | (3) | 消炎止痛劑 | 0.516 | 15.1 | +81.5 | +139.5 | 1.04 | 12.5 | +59.5 | | (4) | 紫外線吸收劑 | 0.293 | 8.55 | +95.4 | +68 | 0.598 | 7.17 | +57.1 | | (5) | 抗癌活性成份 | 0.245 | 7.17 | +397.4 | +4608.4 | 0.348 | 4.17 | -19 | | (6) | 勞務 | 0.15 | 4.39 | +292.2 | -39 | 0.205 | 2.46 | -32.7 | | (7) | 中樞神經系統用藥 | 0.14 | 4.09 | +8.91 | +309.7 | 0.323 | 3.87 | +176.4 | | (8) | 呼吸系統用藥 | 0.043 | 1.26 | -77.3 | -71.9 | 0.433 | 5.19 | -29.9 | | 其他 | 其他 | 0.271 | 7.91 | +5635.8 | +243 | 0.316 | 3.78 | -24.3 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0.0046 | -0.05 | - | | 合計 | 業務營收淨額 | 3.42 | 100 | +65.7 | +35 | 8.35 | 100 | +13.4 | | 2022/02 | 54.6 | 57.1 | 59.5 | 54.6 | +2.7 | +4.96 | (1) | 膽固醇磷酸鹽結合劑 | 0.96 | 46.5 | +2.24 | -5.22 | 1.9 | 38.5 | +9.56 | | (2) | 消炎止痛劑 | 0.284 | 13.8 | +16.1 | +21.4 | 0.529 | 10.7 | +20.3 | | (3) | 維他命D衍生物 | 0.219 | 10.6 | -81 | +194.1 | 1.37 | 27.9 | +97.6 | | (4) | 呼吸系統用藥 | 0.19 | 9.18 | -5.48 | -16.7 | 0.39 | 7.92 | -16.1 | | (5) | 紫外線吸收劑 | 0.15 | 7.25 | -4.01 | +63.7 | 0.306 | 6.2 | +47.9 | | (6) | 中樞神經系統用藥 | 0.129 | 6.22 | +136.1 | +405.6 | 0.183 | 3.72 | +121.3 | | (7) | 抗癌活性成份 | 0.0493 | 2.39 | -7.8 | -80.9 | 0.103 | 2.09 | -75.8 | | (8) | 免疫調節劑 | 0.0473 | 2.29 | +1983.7 | -65.3 | 0.0496 | 1.01 | -87.1 | | (9) | 勞務 | 0.0383 | 1.86 | +131.7 | +1.73 | 0.0549 | 1.11 | -6.08 | | 其他 | 其他 | 0.0047 | 0.23 | -88.3 | -98.6 | 0.0452 | 0.92 | -86.6 | | 減 | 銷貨退回及折讓 | 0.0046 | -0.22 | - | - | 0.0046 | -0.09 | - | | 合計 | 業務營收淨額 | 2.07 | 100 | -27.8 | -15.2 | 4.93 | 100 | +2.05 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2022/01 | 61.1 | 54.4 | 61.9 | 54 | -6.1 | -10.08 | (1) | 維他命D衍生物 | 1.15 | 40.3 | +146.1 | +86 | 1.15 | 40.3 | +86 | | (2) | 膽固醇磷酸鹽結合劑 | 0.939 | 32.8 | -31.9 | +30.3 | 0.939 | 32.8 | +30.3 | | (3) | 消炎止痛劑 | 0.245 | 8.56 | +2.27 | +19 | 0.245 | 8.56 | +19 | | (4) | 呼吸系統用藥 | 0.201 | 7.01 | +45.1 | -15.4 | 0.201 | 7.01 | -15.4 | | (5) | 紫外線吸收劑 | 0.156 | 5.45 | +399.6 | +35.4 | 0.156 | 5.45 | +35.4 | | (6) | 中樞神經系統用藥 | 0.0545 | 1.9 | -89.2 | -4.92 | 0.0545 | 1.9 | -4.92 | | (7) | 抗癌活性成份 | 0.0535 | 1.87 | +60.7 | -67.7 | 0.0535 | 1.87 | -67.7 | | (8) | 勞務 | 0.0165 | 0.58 | -78.4 | -20.3 | 0.0165 | 0.58 | -20.3 | | (9) | 免疫調節劑 | 0.0023 | 0.08 | -97.1 | -99.1 | 0.0023 | 0.08 | -99.1 | | 其他 | 其他 | 0.0405 | 1.42 | -86.2 | +2240.5 | 0.0405 | 1.42 | +2240.5 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 2.86 | 100 | -11 | +19.6 | 2.86 | 100 | +19.6 | | 2021/12 | 56.2 | 60.5 | 62.2 | 55.3 | +4.5 | +8.04 | (1) | 膽固醇磷酸鹽結合劑 | 1.38 | 42.9 | +51.4 | +47 | 12.08 | 38.5 | +0.02 | | (2) | 中樞神經系統用藥 | 0.505 | 15.7 | +402.6 | +17.7 | 1.12 | 3.56 | -8.83 | | (3) | 維他命D衍生物 | 0.469 | 14.6 | -43 | -27 | 6.07 | 19.3 | +1.92 | | (4) | 消炎止痛劑 | 0.239 | 7.45 | -13.3 | -5.7 | 2.27 | 7.23 | +10.9 | | (5) | 呼吸系統用藥 | 0.138 | 4.3 | -64.6 | -40.1 | 1.99 | 6.33 | - | | (6) | 免疫調節劑 | 0.0777 | 2.42 | +9.25 | -54.8 | - | - | - | | (7) | 勞務 | 0.0767 | 2.39 | -2.7 | -76.4 | 1.57 | 4.99 | +1.77 | | (8) | 抗癌活性成份 | 0.0333 | 1.04 | +727.9 | -91.7 | 0.97 | 3.09 | -7.04 | | (9) | 紫外線吸收劑 | 0.0312 | 0.97 | -53.9 | -81.2 | 1.52 | 4.84 | -11.5 | | 其他 | 其他 | 0.294 | 9.15 | -24.2 | +1099.3 | 2.61 | 8.3 | +120.7 | | 減 | 銷貨退回及折讓 | 0.0298 | -0.93 | - | -89.9 | 0.238 | -0.76 | -57.1 | | 合計 | 業務營收淨額 | 3.21 | 100 | +3.34 | -3.57 | 31.42 | 100 | +2.18 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/11 | 59.7 | 56 | 61.4 | 55.8 | -3.2 | -5.41 | (1) | 膽固醇磷酸鹽結合劑 | 0.911 | 29.3 | -7.89 | -3.54 | 10.71 | 37.9 | -3.94 | | (2) | 維他命D衍生物 | 0.822 | 26.4 | +75.3 | +95.7 | 5.6 | 19.8 | +5.42 | | (3) | 呼吸系統用藥 | 0.39 | 12.6 | +28.3 | +33.7 | 1.85 | 6.56 | - | | (4) | 消炎止痛劑 | 0.276 | 8.88 | +555.2 | +85 | 2.03 | 7.2 | +13.2 | | (5) | 中樞神經系統用藥 | 0.1 | 3.23 | -28.3 | +454.6 | 0.613 | 2.17 | -23.1 | | (6) | 勞務 | 0.0788 | 2.53 | +48.2 | -28.4 | 1.49 | 5.28 | +22.7 | | (7) | 免疫調節劑 | 0.0711 | 2.29 | -47.7 | +1280.8 | - | - | - | | (8) | 紫外線吸收劑 | 0.0677 | 2.18 | -40.5 | -40.6 | 1.49 | 5.28 | -4.04 | | (9) | 抗癌活性成份 | 0.004 | 0.13 | -93.2 | -87.6 | 0.937 | 3.32 | +46.2 | | 其他 | 其他 | 0.388 | 12.5 | +47.9 | +1617.7 | 2.31 | 8.2 | +99.9 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | -100 | 0.208 | -0.74 | -20.4 | | 合計 | 業務營收淨額 | 3.11 | 100 | +21 | +49.7 | 28.21 | 100 | +2.87 | | 2021/10 | 61.5 | 59.2 | 63.5 | 55.7 | -3.1 | -4.98 | (1) | 膽固醇磷酸鹽結合劑 | 0.989 | 38.5 | -15.9 | -5.54 | 9.79 | 39 | -3.97 | | (2) | 維他命D衍生物 | 0.469 | 18.3 | -39.8 | +18.4 | 4.78 | 19 | -2.33 | | (3) | 呼吸系統用藥 | 0.304 | 11.8 | +37.4 | +20.9 | 1.46 | 5.82 | - | | (4) | 中樞神經系統用藥 | 0.14 | 5.45 | +1798.2 | +225.6 | 0.512 | 2.04 | -34.2 | | (5) | 免疫調節劑 | 0.136 | 5.29 | - | -8.18 | - | - | - | | (6) | 紫外線吸收劑 | 0.114 | 4.43 | -30.4 | -33.5 | 1.42 | 5.66 | -1.15 | | (7) | 抗癌活性成份 | 0.0592 | 2.3 | -75.2 | +49.5 | 0.933 | 3.72 | +53.3 | | (8) | 勞務 | 0.0532 | 2.07 | -83.1 | -85.6 | 1.41 | 5.62 | +27.7 | | (9) | 消炎止痛劑 | 0.0421 | 1.64 | +650.8 | -30.1 | 1.76 | 6.99 | +6.74 | | 其他 | 其他 | 0.262 | 10.2 | +280 | +3332.1 | 1.93 | 7.67 | +69.7 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0.208 | -0.83 | -3.58 | | 合計 | 業務營收淨額 | 2.57 | 100 | -8.11 | -4.7 | 25.1 | 100 | -0.96 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/09 | 68.2 | 62.3 | 68.6 | 60.3 | -5.7 | -8.38 | (1) | 膽固醇磷酸鹽結合劑 | 1.18 | 42.1 | -3.27 | -10 | 8.81 | 39.1 | -3.79 | | (2) | 維他命D衍生物 | 0.779 | 27.9 | +161.9 | +229.4 | 4.31 | 19.1 | -4.16 | | (3) | 勞務 | 0.316 | 11.3 | +188.7 | +1278.3 | 1.36 | 6.03 | +84.6 | | (4) | 抗癌活性成份 | 0.238 | 8.53 | +2953.6 | +2573.7 | 0.874 | 3.88 | +53.5 | | (5) | 呼吸系統用藥 | 0.221 | 7.92 | +554.8 | -1.61 | 1.16 | 5.13 | - | | (6) | 紫外線吸收劑 | 0.163 | 5.84 | +0.62 | -19.6 | 1.31 | 5.8 | +3.23 | | (7) | 中樞神經系統用藥 | 0.0074 | 0.26 | -67 | -89.5 | 0.372 | 1.65 | -49.4 | | (8) | 消炎止痛劑 | 0.0056 | 0.2 | -85.8 | -96.1 | 1.71 | 7.61 | +8.14 | | 其他 | 其他 | 0.069 | 2.47 | -10.2 | -79.6 | 1.66 | 7.38 | +47.6 | | 減 | 銷貨退回及折讓 | 0.181 | -6.47 | - | - | 0.208 | -0.92 | -3.58 | | 合計 | 業務營收淨額 | 2.8 | 100 | +31.3 | -0.38 | 22.53 | 100 | -0.52 | | 2021/08 | 69.4 | 68 | 76.7 | 66.1 | -0.2 | -0.29 | (1) | 膽固醇磷酸鹽結合劑 | 1.22 | 57.1 | +69 | +39.7 | 7.63 | 38.7 | -2.75 | | (2) | 維他命D衍生物 | 0.297 | 14 | -33.2 | -45.5 | 3.53 | 17.9 | -17.1 | | (3) | 免疫調節劑 | 0.164 | 7.7 | -32 | -49.5 | - | - | - | | (4) | 紫外線吸收劑 | 0.162 | 7.62 | +69.6 | +66.4 | 1.14 | 5.8 | +7.6 | | (5) | 勞務 | 0.109 | 5.13 | +77.5 | +701.9 | 1.04 | 5.29 | +46.3 | | (6) | 消炎止痛劑 | 0.0394 | 1.85 | -81.4 | -78.1 | 1.71 | 8.65 | +18.6 | | (7) | 呼吸系統用藥 | 0.0338 | 1.59 | -43.3 | -84.2 | 0.934 | 4.73 | - | | (8) | 中樞神經系統用藥 | 0.0224 | 1.05 | -62.1 | -93.8 | 0.365 | 1.85 | -45.2 | | (9) | 抗癌活性成份 | 0.0078 | 0.37 | +44.1 | -92.7 | 0.635 | 3.22 | +13.4 | | 其他 | 其他 | 0.0769 | 3.61 | +321.1 | -49.7 | 1.59 | 8.08 | +102.3 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0.0276 | -0.14 | -87.2 | | 合計 | 業務營收淨額 | 2.13 | 100 | +11.1 | -27.2 | 19.74 | 100 | -0.54 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/07 | 80 | 68.2 | 82.5 | 65.5 | -11.7 | -14.64 | (1) | 膽固醇磷酸鹽結合劑 | 0.719 | 37.5 | -20.9 | -34.1 | 6.41 | 36.4 | -8.05 | | (2) | 維他命D衍生物 | 0.445 | 23.2 | -18.4 | +107.2 | 3.23 | 18.3 | -13 | | (3) | 免疫調節劑 | 0.241 | 12.6 | +126.2 | +9503.2 | - | - | - | | (4) | 消炎止痛劑 | 0.212 | 11.1 | +37.4 | -18.3 | 1.67 | 9.48 | +32.4 | | (5) | 紫外線吸收劑 | 0.0958 | 5 | -49.5 | -34.1 | 0.982 | 5.57 | +1.65 | | (6) | 勞務 | 0.0616 | 3.21 | -61.4 | -50.7 | 0.934 | 5.3 | +33.5 | | (7) | 呼吸系統用藥 | 0.0596 | 3.11 | +17975.8 | -63.5 | 0.9 | 5.11 | - | | (8) | 中樞神經系統用藥 | 0.059 | 3.08 | +120.3 | +40.9 | 0.342 | 1.94 | +13.4 | | (9) | 抗癌活性成份 | 0.0054 | 0.28 | -89.4 | -94.7 | 0.627 | 3.56 | +38.5 | | 其他 | 其他 | 0.0183 | 0.95 | -97.5 | -41.5 | 1.52 | 8.62 | +138.8 | | 減 | 銷貨退回及折讓 | 0.0015 | -0.08 | -4.94 | - | 0.0276 | -0.16 | -85.7 | | 合計 | 業務營收淨額 | 1.92 | 100 | -33.1 | -20.6 | 17.61 | 100 | +4.08 | | 2021/06 | 92.5 | 79.9 | 104 | 78.2 | -13.6 | -14.55 | (1) | 膽固醇磷酸鹽結合劑 | 0.91 | 31.8 | -8.73 | -20.5 | 5.69 | 36.3 | -3.2 | | (2) | 維他命D衍生物 | 0.546 | 19 | +42.9 | +17.8 | 2.79 | 17.8 | -20.3 | | (3) | 紫外線吸收劑 | 0.19 | 6.62 | +6.02 | +46.4 | 0.886 | 5.65 | +8 | | (4) | 勞務 | 0.16 | 5.57 | -36.2 | -37.5 | 0.872 | 5.56 | +51.8 | | (5) | 消炎止痛劑 | 0.155 | 5.4 | -39.5 | -48.1 | 1.46 | 9.28 | +45.6 | | (6) | 免疫調節劑 | 0.107 | 3.72 | - | +1666.8 | - | - | - | | (7) | 抗癌活性成份 | 0.0512 | 1.79 | -27.4 | -0.74 | 0.622 | 3.96 | +77.4 | | (8) | 中樞神經系統用藥 | 0.0268 | 0.93 | -73.7 | -59.8 | 0.283 | 1.81 | +8.93 | | (9) | 呼吸系統用藥 | 0.0003 | 0.01 | -88.7 | -99.8 | 0.841 | 5.36 | - | | 其他 | 其他 | 0.722 | 25.2 | +142.8 | +168.2 | 1.5 | 9.56 | +148.2 | | 減 | 銷貨退回及折讓 | 0.0016 | -0.06 | -92.1 | -98.2 | 0.0261 | -0.17 | -86.5 | | 合計 | 業務營收淨額 | 2.86 | 100 | +13.9 | +2.73 | 15.69 | 100 | +8.19 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/05 | 58.5 | 93.5 | 108 | 53.6 | +35.7 | +61.76 | (1) | 膽固醇磷酸鹽結合劑 | 0.997 | 39.6 | -10.9 | -11.6 | 4.78 | 37.3 | +0.99 | | (2) | 維他命D衍生物 | 0.382 | 15.2 | -44.5 | -23.3 | 2.24 | 17.5 | -26.2 | | (3) | 消炎止痛劑 | 0.255 | 10.2 | -34.7 | -6.01 | 1.3 | 10.1 | +85.2 | | (4) | 勞務 | 0.25 | 9.95 | +58.6 | +108.5 | 0.713 | 5.56 | +123.1 | | (5) | 紫外線吸收劑 | 0.179 | 7.11 | +30.8 | +23.6 | 0.696 | 5.43 | +0.8 | | (6) | 中樞神經系統用藥 | 0.102 | 4.04 | +166.4 | +398.8 | 0.257 | 2 | +32.6 | | (7) | 抗癌活性成份 | 0.0704 | 2.8 | -0.49 | +102.9 | 0.571 | 4.45 | +90.9 | | (8) | 呼吸系統用藥 | 0.0029 | 0.12 | -98.7 | -97.3 | 0.84 | 6.55 | - | | 其他 | 其他 | 0.297 | 11.8 | +375.4 | +1081 | 0.777 | 6.06 | +132.1 | | 減 | 銷貨退回及折讓 | 0.0204 | -0.81 | +399.8 | - | 0.0245 | -0.19 | -75.9 | | 合計 | 業務營收淨額 | 2.52 | 100 | -14.7 | -3.25 | 12.83 | 100 | +9.49 | | 2021/04 | 57.5 | 57.8 | 63.7 | 55.4 | +1 | +1.76 | (1) | 膽固醇磷酸鹽結合劑 | 1.12 | 37.9 | +19.7 | +24.3 | 3.79 | 36.7 | +4.93 | | (2) | 維他命D衍生物 | 0.688 | 23.3 | +44.6 | +17.8 | 1.86 | 18 | -26.7 | | (3) | 消炎止痛劑 | 0.391 | 13.3 | +81.7 | +92.1 | 1.05 | 10.1 | +142.8 | | (4) | 呼吸系統用藥 | 0.22 | 7.45 | +43.9 | -12.7 | 0.837 | 8.12 | - | | (5) | 勞務 | 0.158 | 5.35 | -36 | +8.19 | 0.463 | 4.49 | +131.9 | | (6) | 紫外線吸收劑 | 0.137 | 4.64 | -21.5 | -6.4 | 0.517 | 5.02 | -5.23 | | (7) | 抗癌活性成份 | 0.0708 | 2.4 | +1258.9 | -41.3 | 0.5 | 4.85 | +89.3 | | (8) | 免疫調節劑 | 0.0692 | 2.35 | -68.3 | +213.6 | 0.672 | 6.52 | +519.9 | | (9) | 中樞神經系統用藥 | 0.0381 | 1.29 | +11.5 | +92.5 | 0.155 | 1.5 | -10.5 | | 其他 | 其他 | 0.0626 | 2.12 | -20.8 | +224.4 | 0.48 | 4.66 | +54.9 | | 減 | 銷貨退回及折讓 | 0.0041 | -0.14 | - | -95.4 | 0.0041 | -0.04 | -96 | | 合計 | 業務營收淨額 | 2.95 | 100 | +16.3 | +18.5 | 10.31 | 100 | +13.1 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/03 | 51.8 | 56.8 | 63 | 46.75 | +5.7 | +11.15 | (1) | 膽固醇磷酸鹽結合劑 | 0.935 | 36.9 | -7.63 | -21.8 | 2.67 | 36.2 | -1.5 | | (2) | 維他命D衍生物 | 0.476 | 18.8 | +538.7 | -46.3 | 1.17 | 15.9 | -40.1 | | (3) | 勞務 | 0.246 | 9.72 | +553.9 | +729.6 | 0.305 | 4.14 | +468.1 | | (4) | 免疫調節劑 | 0.218 | 8.59 | +59.6 | +694.7 | 0.603 | 8.19 | +598.1 | | (5) | 消炎止痛劑 | 0.215 | 8.49 | -8 | +64.2 | 0.655 | 8.9 | +188.2 | | (6) | 紫外線吸收劑 | 0.174 | 6.87 | +90.4 | +18.8 | 0.381 | 5.17 | -4.81 | | (7) | 呼吸系統用藥 | 0.153 | 6.02 | -32.9 | -41.3 | 0.618 | 8.39 | - | | (8) | 中樞神經系統用藥 | 0.0342 | 1.35 | +34.4 | +4.85 | 0.117 | 1.59 | -23.8 | | (9) | 抗癌活性成份 | 0.0052 | 0.21 | -98 | -92.1 | 0.43 | 5.83 | +198.8 | | 其他 | 其他 | 0.0789 | 3.11 | -76.6 | +11.7 | 0.418 | 5.67 | +43.7 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | -100 | 0 | 0 | -100 | | 合計 | 業務營收淨額 | 2.54 | 100 | +4.14 | -12.2 | 7.36 | 100 | +11.1 | | 2021/02 | 47.1 | 51.1 | 57 | 45.9 | +4.15 | +8.84 | (1) | 膽固醇磷酸鹽結合劑 | 1.01 | 41.6 | +40.6 | +80.6 | 1.73 | 35.9 | +14.5 | | (2) | 抗癌活性成份 | 0.259 | 10.6 | +55.9 | +12154 | 0.424 | 8.79 | +447.6 | | (3) | 消炎止痛劑 | 0.234 | 9.61 | +13.8 | +145.5 | 0.44 | 9.11 | +357.1 | | (4) | 呼吸系統用藥 | 0.228 | 9.35 | -4.08 | +24.8 | 0.465 | 9.63 | - | | (5) | 免疫調節劑 | 0.136 | 5.61 | -45 | +820.4 | 0.385 | 7.97 | +553.2 | | (6) | 紫外線吸收劑 | 0.0914 | 3.76 | -20.6 | -14.4 | 0.207 | 4.28 | -18.4 | | (7) | 維他命D衍生物 | 0.0745 | 3.06 | -88 | -90.9 | 0.695 | 14.4 | -34.9 | | (8) | 勞務 | 0.0377 | 1.55 | +81.7 | +112.5 | 0.0584 | 1.21 | +143.9 | | (9) | 中樞神經系統用藥 | 0.0254 | 1.04 | -55.6 | -71.1 | 0.0827 | 1.71 | -31.5 | | 其他 | 其他 | 0.337 | 13.8 | +19371.1 | +557.8 | 0.339 | 7.01 | +54 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 2.43 | 100 | +1.78 | +25.1 | 4.83 | 100 | +29.2 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2021/01 | 47.6 | 46.95 | 47.8 | 43.15 | 0 | 0 | (1) | 膽固醇磷酸鹽結合劑 | 0.72 | 30.1 | -23.2 | -24.4 | 0.72 | 30.1 | -24.4 | | (2) | 維他命D衍生物 | 0.62 | 25.9 | -3.41 | +148.5 | 0.62 | 25.9 | +148.5 | | (3) | 免疫調節劑 | 0.248 | 10.4 | +44.5 | +463.3 | 0.248 | 10.4 | +463.3 | | (4) | 呼吸系統用藥 | 0.237 | 9.92 | +2.86 | - | 0.237 | 9.92 | - | | (5) | 消炎止痛劑 | 0.206 | 8.6 | -19 | +22757.8 | 0.206 | 8.6 | +22757.8 | | (6) | 抗癌活性成份 | 0.166 | 6.93 | -58.8 | +120 | 0.166 | 6.93 | +120 | | (7) | 紫外線吸收劑 | 0.115 | 4.82 | -30.7 | -21.4 | 0.115 | 4.82 | -21.4 | | (8) | 中樞神經系統用藥 | 0.0573 | 2.39 | -86.7 | +74.8 | 0.0573 | 2.39 | +74.8 | | (9) | 勞務 | 0.0207 | 0.87 | -93.6 | +233.4 | 0.0207 | 0.87 | +233.4 | | 其他 | 其他 | 0.0017 | 0.07 | -92.9 | -99 | 0.0017 | 0.07 | -99 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0 | 0 | - | | 合計 | 業務營收淨額 | 2.39 | 100 | -28.2 | +33.6 | 2.39 | 100 | +33.6 | | 2020/12 | 50.4 | 46.95 | 51.2 | 44.8 | -3.05 | -6.1 | (1) | 膽固醇磷酸鹽結合劑 | 0.938 | 28.1 | -0.71 | -15.6 | 12.08 | 39.3 | +6.07 | | (2) | 維他命D衍生物 | 0.642 | 19.3 | +52.8 | +13.8 | 5.95 | 19.4 | +16.3 | | (3) | 中樞神經系統用藥 | 0.429 | 12.9 | +2269 | -17 | 1.23 | 3.99 | -44.6 | | (4) | 抗癌活性成份 | 0.403 | 12.1 | +1147 | +633.4 | 1.04 | 3.39 | -23.5 | | (5) | 勞務 | 0.325 | 9.75 | +195 | +114.3 | 1.54 | 5.01 | +61.9 | | (6) | 消炎止痛劑 | 0.254 | 7.62 | +70.2 | +159.5 | 2.05 | 6.66 | +31.1 | | (7) | 呼吸系統用藥 | 0.231 | 6.92 | -21 | - | - | - | - | | (8) | 免疫調節劑 | 0.172 | 5.16 | +3235.7 | +3.59 | - | - | - | | (9) | 紫外線吸收劑 | 0.166 | 4.99 | +45.9 | +14 | 1.72 | 5.58 | - | | (10) | 抗生素 | 0.0427 | 1.28 | +196.6 | -44 | 1.19 | 3.87 | - | | 其他 | 其他 | 0.0245 | 0.74 | +8.6 | -74.3 | 1.18 | 3.84 | +13.2 | | 減 | 銷貨退回及折讓 | 0.294 | -8.83 | +544.4 | +176.2 | 0.556 | -1.81 | -21.5 | | 合計 | 業務營收淨額 | 3.33 | 100 | +60.5 | +16 | 30.75 | 100 | +11.6 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/11 | 47.95 | 50 | 50.6 | 47.95 | +1.9 | +3.95 | (1) | 膽固醇磷酸鹽結合劑 | 0.944 | 45.5 | -9.8 | -0.99 | 11.14 | 40.6 | +8.41 | | (2) | 維他命D衍生物 | 0.42 | 20.2 | +6.06 | +73.8 | 5.31 | 19.4 | +16.6 | | (3) | 呼吸系統用藥 | 0.292 | 14.1 | +15.9 | +40.7 | - | - | - | | (4) | 消炎止痛劑 | 0.149 | 7.18 | +147.6 | +43.6 | 1.79 | 6.54 | +22.5 | | (5) | 紫外線吸收劑 | 0.114 | 5.48 | -33.5 | +8.74 | 1.55 | 5.66 | - | | (6) | 勞務 | 0.11 | 5.3 | -70.2 | +52.1 | 1.22 | 4.43 | +51.9 | | (7) | 抗癌活性成份 | 0.0323 | 1.56 | -18.4 | -81.2 | 0.641 | 2.34 | -51 | | (8) | 中樞神經系統用藥 | 0.0181 | 0.87 | -57.9 | -52.3 | 0.797 | 2.91 | -53 | | (9) | 抗生素 | 0.0144 | 0.69 | -91.1 | -57.8 | 1.15 | 4.18 | - | | (10) | 免疫調節劑 | 0.0052 | 0.25 | -96.5 | -96.2 | - | - | - | | 其他 | 其他 | 0.0226 | 1.09 | +195.4 | -75.9 | 1.16 | 4.22 | +22 | | 減 | 銷貨退回及折讓 | 0.0456 | -2.2 | - | +1204 | 0.262 | -0.95 | -56.5 | | 合計 | 業務營收淨額 | 2.08 | 100 | -23 | -3.57 | 27.42 | 100 | +11 | | 2020/10 | 50.6 | 48.1 | 52.3 | 47.5 | -2 | -3.99 | (1) | 膽固醇磷酸鹽結合劑 | 1.05 | 38.8 | -19.9 | +2.74 | 10.2 | 40.2 | +9.37 | | (2) | 維他命D衍生物 | 0.396 | 14.7 | +67.5 | +17.6 | 4.89 | 19.3 | +13.4 | | (3) | 勞務 | 0.369 | 13.7 | +1513.5 | +219 | 1.11 | 4.36 | +51.9 | | (4) | 呼吸系統用藥 | 0.252 | 9.34 | +11.9 | +68.4 | - | - | - | | (5) | 紫外線吸收劑 | 0.171 | 6.35 | -15.8 | +71.6 | 1.44 | 5.67 | - | | (6) | 抗生素 | 0.161 | 5.99 | +189.1 | - | 1.13 | 4.47 | - | | (7) | 免疫調節劑 | 0.148 | 5.49 | -23.2 | +254.4 | - | - | - | | (8) | 消炎止痛劑 | 0.0602 | 2.23 | -58.2 | -77.3 | 1.64 | 6.49 | +20.9 | | (9) | 中樞神經系統用藥 | 0.043 | 1.6 | -38.9 | -29.5 | 0.779 | 3.07 | -53.1 | | (10) | 抗癌活性成份 | 0.0396 | 1.47 | +343.6 | +160 | 0.609 | 2.4 | -46.4 | | 其他 | 其他 | 0.0076 | 0.28 | -97.7 | -96.1 | 1.13 | 4.48 | +32.7 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | -100 | 0.216 | -0.85 | -63.9 | | 合計 | 業務營收淨額 | 2.7 | 100 | -3.95 | +23.1 | 25.35 | 100 | +12.4 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/09 | 50.3 | 50.1 | 53.8 | 48.3 | -0.1 | -0.2 | (1) | 膽固醇磷酸鹽結合劑 | 1.31 | 46.6 | +50.2 | -11 | 9.15 | 40.4 | +10.2 | | (2) | 維他命D衍生物 | 0.237 | 8.43 | -56.7 | -55.1 | 4.49 | 19.8 | +13 | | (3) | 呼吸系統用藥 | 0.225 | 8.02 | +5.05 | +5.81 | - | - | - | | (4) | 紫外線吸收劑 | 0.203 | 7.24 | +108.4 | +701.8 | 1.27 | 5.59 | - | | (5) | 免疫調節劑 | 0.193 | 6.87 | -40.6 | +20635.5 | - | - | - | | (6) | 消炎止痛劑 | 0.144 | 5.13 | -20.1 | +104.5 | 1.58 | 7 | +44.8 | | (7) | 中樞神經系統用藥 | 0.0704 | 2.51 | -80.6 | -72.5 | 0.736 | 3.25 | -54 | | (8) | 抗生素 | 0.0558 | 1.99 | -29.9 | -36.7 | 0.972 | 4.29 | - | | (9) | 勞務 | 0.0229 | 0.82 | +67.9 | +142.2 | 0.736 | 3.25 | +20.3 | | (10) | 抗癌活性成份 | 0.0089 | 0.32 | -91.7 | -68.5 | 0.569 | 2.51 | -49.2 | | 其他 | 其他 | 0.339 | 12.1 | +121.7 | +301.4 | 1.13 | 4.98 | +71.1 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0.216 | -0.95 | -55.6 | | 合計 | 業務營收淨額 | 2.81 | 100 | -4.12 | +4.04 | 22.65 | 100 | +11.3 | | 2020/08 | 50.2 | 50.2 | 57.6 | 48.15 | +0.35 | +0.7 | (1) | 膽固醇磷酸鹽結合劑 | 0.871 | 29.8 | -20.3 | -19.8 | 7.85 | 39.5 | +14.7 | | (2) | 維他命D衍生物 | 0.546 | 18.6 | +153.8 | +7.37 | 4.26 | 21.5 | +23.4 | | (3) | 中樞神經系統用藥 | 0.363 | 12.4 | +767.8 | +60.1 | 0.665 | 3.35 | -50.4 | | (4) | 免疫調節劑 | 0.325 | 11.1 | +12842.2 | +3047.8 | - | - | - | | (5) | 呼吸系統用藥 | 0.214 | 7.32 | +31.1 | - | - | - | - | | (6) | 消炎止痛劑 | 0.18 | 6.16 | -30.7 | -15.4 | 1.44 | 7.26 | +40.7 | | (7) | 抗癌活性成份 | 0.107 | 3.66 | +4.69 | -57.7 | 0.56 | 2.82 | -48.7 | | (8) | 紫外線吸收劑 | 0.0976 | 3.33 | -32.9 | - | 1.06 | 5.36 | - | | (9) | 抗生素 | 0.0796 | 2.72 | -66.1 | -14.8 | 0.916 | 4.62 | - | | (10) | 勞務 | 0.0136 | 0.47 | -89.1 | -86.7 | 0.713 | 3.59 | +18.4 | | 其他 | 其他 | 0.153 | 5.22 | +389 | +10.8 | 0.788 | 3.97 | +37.3 | | 減 | 銷貨退回及折讓 | 0.0229 | -0.78 | - | -85.6 | 0.216 | -1.09 | -47.5 | | 合計 | 業務營收淨額 | 2.93 | 100 | +21.2 | +18.4 | 19.84 | 100 | +12.4 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/07 | 55.8 | 49.85 | 59 | 47 | -5.35 | -9.69 | (1) | 膽固醇磷酸鹽結合劑 | 1.09 | 45.3 | -4.58 | +5.24 | 6.97 | 41.2 | +21.2 | | (2) | 消炎止痛劑 | 0.26 | 10.8 | -12.7 | +41 | 1.26 | 7.45 | +55.4 | | (3) | 抗生素 | 0.235 | 9.73 | +2407 | +152.7 | 0.836 | 4.94 | - | | (4) | 維他命D衍生物 | 0.215 | 8.9 | -53.6 | -14.5 | 3.71 | 21.9 | +26.2 | | (5) | 呼吸系統用藥 | 0.163 | 6.77 | -12.6 | -27.2 | - | - | - | | (6) | 紫外線吸收劑 | 0.145 | 6.02 | +12.3 | +305.4 | 0.966 | 5.71 | -31 | | (7) | 勞務 | 0.125 | 5.17 | -51.1 | +12.3 | 0.699 | 4.13 | +39.9 | | (8) | 抗癌活性成份 | 0.102 | 4.24 | +98.7 | -43.9 | 0.453 | 2.68 | -46.1 | | (9) | 中樞神經系統用藥 | 0.0418 | 1.73 | -37.1 | -89.4 | 0.302 | 1.78 | -72.9 | | (10) | 免疫調節劑 | 0.0025 | 0.1 | -58.4 | -85.3 | - | - | - | | 其他 | 其他 | 0.0312 | 1.29 | -88.4 | -83.8 | 0.636 | 3.76 | +45.6 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0.193 | -1.14 | -23.6 | | 合計 | 業務營收淨額 | 2.41 | 100 | -13.4 | -11.4 | 16.92 | 100 | +11.4 | | 2020/06 | 52 | 55.2 | 61.5 | 47 | +4.5 | +8.88 | (1) | 膽固醇磷酸鹽結合劑 | 1.15 | 41.1 | +1.53 | +52 | 5.88 | 40.6 | +24.8 | | (2) | 維他命D衍生物 | 0.463 | 16.6 | -6.94 | -17.2 | 3.5 | 24.1 | +30 | | (3) | 消炎止痛劑 | 0.298 | 10.7 | +9.53 | +131.3 | 1 | 6.9 | +59.6 | | (4) | 勞務 | 0.255 | 9.15 | +112.7 | +213.5 | 0.575 | 3.96 | +47.8 | | (5) | 呼吸系統用藥 | 0.187 | 6.7 | +69.5 | +250.1 | - | - | - | | (6) | 紫外線吸收劑 | 0.13 | 4.64 | -10.5 | +110.2 | 0.82 | 5.66 | -39.9 | | (7) | 中樞神經系統用藥 | 0.0666 | 2.39 | +226.9 | +91.8 | 0.26 | 1.79 | -63.8 | | (8) | 抗癌活性成份 | 0.0516 | 1.85 | +48.5 | -60.1 | 0.351 | 2.42 | -46.7 | | (9) | 抗生素 | 0.0094 | 0.34 | -96.2 | - | 0.601 | 4.15 | - | | (10) | 免疫調節劑 | 0.006 | 0.22 | - | - | - | - | - | | 其他 | 其他 | 0.269 | 9.66 | +969.5 | +10802.8 | 0.604 | 4.17 | +148 | | 減 | 銷貨退回及折讓 | 0.0918 | -3.29 | - | - | 0.193 | -1.33 | -23.5 | | 合計 | 業務營收淨額 | 2.79 | 100 | +7.27 | +54.5 | 14.5 | 100 | +16.4 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/05 | 51.3 | 50.7 | 66.8 | 48.8 | +0.4 | +0.8 | (1) | 膽固醇磷酸鹽結合劑 | 1.13 | 43.4 | +25.2 | +79.9 | 4.74 | 40.4 | +19.6 | | (2) | 維他命D衍生物 | 0.498 | 19.1 | -14.7 | +15.3 | 3.03 | 25.9 | +42.4 | | (3) | 消炎止痛劑 | 0.272 | 10.5 | +33.5 | +76.8 | 0.703 | 6 | +41.1 | | (4) | 抗生素 | 0.247 | 9.51 | +50.3 | +914.7 | 0.592 | 5.05 | - | | (5) | 紫外線吸收劑 | 0.145 | 5.57 | -0.95 | -31.4 | 0.691 | 5.9 | -47 | | (6) | 勞務 | 0.12 | 4.61 | -17.7 | +354.9 | 0.319 | 2.73 | +3.92 | | (7) | 呼吸系統用藥 | 0.11 | 4.24 | -56.2 | -18.9 | - | - | - | | (8) | 抗癌活性成份 | 0.0347 | 1.34 | -71.2 | -51.7 | 0.299 | 2.55 | -43.4 | | (9) | 中樞神經系統用藥 | 0.0204 | 0.78 | +2.83 | -47.2 | 0.194 | 1.65 | -71.7 | | 其他 | 其他 | 0.0252 | 0.97 | +30.6 | -47.2 | 0.335 | 2.86 | +38.9 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0.101 | -0.87 | -59.8 | | 合計 | 業務營收淨額 | 2.6 | 100 | +4.46 | +31.5 | 11.71 | 100 | +9.99 | | 2020/04 | 37.45 | 50.3 | 50.3 | 37.3 | +12.85 | +34.31 | (1) | 膽固醇磷酸鹽結合劑 | 0.901 | 36.2 | -24.7 | +12.8 | 3.61 | 39.6 | +8.25 | | (2) | 維他命D衍生物 | 0.584 | 23.5 | -34.1 | +16.1 | 2.54 | 27.8 | +49.3 | | (3) | 呼吸系統用藥 | 0.252 | 10.1 | -3.3 | +158.3 | - | - | - | | (4) | 消炎止痛劑 | 0.204 | 8.18 | +55.3 | +56.5 | 0.431 | 4.73 | +25.2 | | (5) | 抗生素 | 0.164 | 6.61 | +194.4 | - | 0.345 | 3.78 | - | | (6) | 紫外線吸收劑 | 0.146 | 5.87 | -0.34 | -53.4 | 0.546 | 5.99 | -50 | | (7) | 勞務 | 0.146 | 5.86 | +390.9 | +76.2 | 0.199 | 2.19 | -29 | | (8) | 抗癌活性成份 | 0.121 | 4.84 | +81.8 | +89.9 | 0.264 | 2.9 | -42.1 | | (9) | 免疫調節劑 | 0.0221 | 0.89 | -19.5 | -71.2 | 0.108 | 1.19 | -53.6 | | (10) | 中樞神經系統用藥 | 0.0198 | 0.8 | -39.3 | -56.2 | 0.173 | 1.9 | -73.2 | | 其他 | 其他 | 0.0193 | 0.77 | -72.7 | -63.6 | 0.31 | 3.4 | +60.1 | | 減 | 銷貨退回及折讓 | 0.0888 | -3.57 | +604.4 | +1848 | 0.101 | -1.11 | -59.6 | | 合計 | 業務營收淨額 | 2.49 | 100 | -13.9 | +15.3 | 9.12 | 100 | +5.09 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/03 | 39.2 | 37.45 | 53.9 | 29.75 | -2.25 | -5.67 | (1) | 膽固醇磷酸鹽結合劑 | 1.2 | 41.4 | +113.2 | +48.4 | 2.71 | 40.9 | +6.83 | | (2) | 維他命D衍生物 | 0.886 | 30.7 | +8.41 | +63.7 | 1.95 | 29.5 | +63.2 | | (3) | 呼吸系統用藥 | 0.26 | 9.01 | +42.8 | +343.8 | - | - | - | | (4) | 紫外線吸收劑 | 0.147 | 5.07 | +37.2 | -15 | 0.4 | 6.04 | -48.6 | | (5) | 消炎止痛劑 | 0.131 | 4.54 | +37.6 | +1.86 | 0.227 | 3.43 | +6.14 | | (6) | 抗癌活性成份 | 0.0663 | 2.29 | +3041.7 | +33.1 | 0.144 | 2.17 | -63.4 | | (7) | 抗生素 | 0.0559 | 1.93 | +492.5 | -70.7 | 0.18 | 2.72 | -41.1 | | (8) | 中樞神經系統用藥 | 0.0326 | 1.13 | -63 | -3.55 | 0.153 | 2.31 | -74.5 | | (9) | 勞務 | 0.0297 | 1.03 | +67.5 | -62.3 | 0.0536 | 0.81 | -72.9 | | (10) | 免疫調節劑 | 0.0274 | 0.95 | +84.9 | -69.1 | 0.0863 | 1.3 | -45 | | 其他 | 其他 | 0.0707 | 2.45 | +38 | +7583.7 | 0.291 | 4.38 | +106.7 | | 減 | 銷貨退回及折讓 | 0.0126 | -0.44 | - | -13.7 | 0.0126 | -0.19 | -94.9 | | 合計 | 業務營收淨額 | 2.89 | 100 | +48.5 | +35.4 | 6.63 | 100 | +1.71 | | 2020/02 | 41.8 | 39.7 | 44.8 | 39.05 | -2.1 | -5.02 | (1) | 維他命D衍生物 | 0.817 | 42 | +227.5 | +205 | 1.07 | 28.5 | +62.8 | | (2) | 膽固醇磷酸鹽結合劑 | 0.561 | 28.8 | -41.1 | -30.5 | 1.51 | 40.5 | -12.5 | | (3) | 呼吸系統用藥 | 0.182 | 9.37 | - | +79.9 | - | - | - | | (4) | 紫外線吸收劑 | 0.107 | 5.49 | -27.1 | -58.7 | 0.253 | 6.78 | -58.2 | | (5) | 消炎止痛劑 | 0.0953 | 4.9 | +10490 | +13.4 | 0.0962 | 2.57 | +12.6 | | (6) | 中樞神經系統用藥 | 0.088 | 4.52 | +168.7 | +17.7 | 0.121 | 3.23 | -78.7 | | (7) | 勞務 | 0.0177 | 0.91 | +185 | -78.1 | 0.024 | 0.64 | -79.9 | | (8) | 免疫調節劑 | 0.0148 | 0.76 | -66.4 | -66.4 | 0.0589 | 1.58 | -13.6 | | (9) | 抗生素 | 0.0094 | 0.48 | -91.8 | -63.5 | 0.124 | 3.33 | +7.79 | | (10) | 抗癌活性成份 | 0.0021 | 0.11 | -97.2 | -98.6 | 0.0775 | 2.07 | -77.4 | | 其他 | 其他 | 0.0512 | 2.63 | -69.6 | -1.08 | 0.22 | 5.88 | +57.4 | | 減 | 銷貨退回及折讓 | 0 | 0 | - | -100 | 0 | 0 | -100 | | 合計 | 業務營收淨額 | 1.95 | 100 | +8.63 | +3.35 | 3.74 | 100 | -14.7 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2020/01 | 41.9 | 41.8 | 44.75 | 39.7 | -0.05 | -0.12 | (1) | 膽固醇磷酸鹽結合劑 | 0.952 | 53.2 | -14.3 | +3.14 | 0.952 | 53.2 | +3.14 | | (2) | 維他命D衍生物 | 0.25 | 13.9 | -55.8 | -35.6 | 0.25 | 13.9 | -35.6 | | (3) | 紫外線吸收劑 | 0.147 | 8.18 | +0.56 | -57.9 | 0.147 | 8.18 | -57.9 | | (4) | 抗生素 | 0.115 | 6.42 | +50.7 | +28.4 | 0.115 | 6.42 | +28.4 | | (5) | 抗癌活性成份 | 0.0754 | 4.21 | +37.3 | -61 | 0.0754 | 4.21 | -61 | | (6) | 免疫調節劑 | 0.0441 | 2.46 | -73.4 | +83 | 0.0441 | 2.46 | +83 | | (7) | 中樞神經系統用藥 | 0.0328 | 1.83 | -93.7 | -93.3 | 0.0328 | 1.83 | -93.3 | | (8) | 勞務 | 0.0062 | 0.35 | -95.9 | -83.8 | 0.0062 | 0.35 | -83.8 | | (9) | 消炎止痛劑 | 0.0009 | 0.05 | -99.1 | -34.8 | 0.0009 | 0.05 | -34.8 | | 其他 | 其他 | 0.169 | 9.42 | +77.1 | +91.8 | 0.169 | 9.42 | +91.8 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | -100 | 0 | 0 | -100 | | 合計 | 業務營收淨額 | 1.79 | 100 | -37.7 | -28.3 | 1.79 | 100 | -28.3 | | 2019/12 | 42.6 | 41.85 | 45.55 | 39 | -1.2 | -2.79 | (1) | 膽固醇磷酸鹽結合劑 | 1.11 | 38.7 | +16.5 | -7.86 | 11.39 | 41.3 | -21.4 | | (2) | 維他命D衍生物 | 0.564 | 19.6 | +133.5 | +210.2 | 5.12 | 18.6 | +28.4 | | (3) | 中樞神經系統用藥 | 0.517 | 18 | +1262.2 | +469.6 | 2.21 | 8.03 | +30.9 | | (4) | 免疫調節劑 | 0.166 | 5.77 | +22.7 | -52.8 | - | - | - | | (5) | 勞務 | 0.152 | 5.27 | +109.4 | +474.3 | 0.952 | 3.45 | +8 | | (6) | 紫外線吸收劑 | 0.146 | 5.07 | +39.2 | -42.9 | - | - | - | | (7) | 消炎止痛劑 | 0.0978 | 3.41 | -5.84 | +20281.2 | 1.56 | 5.67 | +245 | | (8) | 抗生素 | 0.0762 | 2.65 | +123.5 | - | - | - | - | | (9) | 抗癌活性成份 | 0.0549 | 1.91 | -68.1 | -68.8 | 1.36 | 4.95 | +48.7 | | 其他 | 其他 | 0.0952 | 3.31 | +1.63 | -18.3 | 1.04 | 3.79 | +4.56 | | 減 | 銷貨退回及折讓 | 0.106 | -3.71 | +2942.9 | -53.8 | 0.708 | -2.57 | +59.3 | | 合計 | 業務營收淨額 | 2.87 | 100 | +33.4 | +19.1 | 27.57 | 100 | +2.47 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2019/11 | 38.2 | 43.05 | 44.7 | 35.3 | +5.1 | +13.44 | (1) | 膽固醇磷酸鹽結合劑 | 0.954 | 44.3 | -6.4 | -14.5 | 10.28 | 41.6 | -22.6 | | (2) | 維他命D衍生物 | 0.242 | 11.2 | -28.3 | -53.1 | 4.56 | 18.4 | +19.7 | | (3) | 呼吸系統用藥 | 0.208 | 9.64 | +38.8 | +254.5 | - | - | - | | (4) | 抗癌活性成份 | 0.172 | 7.98 | +1029.8 | +154.8 | 1.31 | 5.3 | +76.7 | | (5) | 免疫調節劑 | 0.135 | 6.28 | +223.4 | +841 | - | - | - | | (6) | 紫外線吸收劑 | 0.105 | 4.86 | +4.95 | +523 | - | - | - | | (7) | 消炎止痛劑 | 0.104 | 4.82 | -60.9 | +526.3 | 1.46 | 5.93 | +223.7 | | (8) | 勞務 | 0.0724 | 3.36 | -37.5 | +342.5 | 0.8 | 3.24 | -6.39 | | (9) | 中樞神經系統用藥 | 0.038 | 1.76 | -37.8 | -87.6 | 1.7 | 6.87 | +6.01 | | (10) | 抗生素 | 0.0341 | 1.58 | +341100 | - | - | - | - | | 其他 | 其他 | 0.0937 | 4.35 | -52.3 | -59.2 | 0.949 | 3.84 | +7.59 | | 減 | 銷貨退回及折讓 | 0.0035 | -0.16 | -96.9 | -51.2 | 0.601 | -2.44 | +181.2 | | 合計 | 業務營收淨額 | 2.15 | 100 | -1.66 | -8.37 | 24.69 | 100 | +0.83 | | 2019/10 | 33.35 | 37.95 | 38.75 | 33.2 | +4.65 | +13.96 | (1) | 膽固醇磷酸鹽結合劑 | 1.02 | 46.5 | -30.6 | -5.34 | 9.33 | 41.4 | -23.4 | | (2) | 維他命D衍生物 | 0.337 | 15.4 | -36.1 | -48 | 4.31 | 19.1 | +31 | | (3) | 消炎止痛劑 | 0.266 | 12.1 | +277.3 | +1567.3 | 1.36 | 6.04 | +212.2 | | (4) | 呼吸系統用藥 | 0.15 | 6.83 | -29.7 | +3564.7 | - | - | - | | (5) | 勞務 | 0.116 | 5.29 | +1125.1 | +45 | 0.728 | 3.23 | -13.2 | | (6) | 紫外線吸收劑 | 0.0998 | 4.56 | +293.6 | +65.7 | - | - | - | | (7) | 中樞神經系統用藥 | 0.061 | 2.79 | -76.2 | -25 | 1.66 | 7.36 | +28.2 | | (8) | 免疫調節劑 | 0.0418 | 1.91 | +4392.5 | +31.7 | - | - | - | | (9) | 抗癌活性成份 | 0.0152 | 0.7 | -46.2 | -88 | 1.14 | 5.04 | +68.9 | | (10) | 抗生素 | 0 | 0 | -100 | - | - | - | - | | 其他 | 其他 | 0.197 | 8.97 | +132.9 | +75.8 | 0.855 | 3.79 | +31.2 | | 減 | 銷貨退回及折讓 | 0.112 | -5.09 | +49.2 | +111420 | 0.598 | -2.65 | +189.2 | | 合計 | 業務營收淨額 | 2.19 | 100 | -18.8 | -2.09 | 22.54 | 100 | +1.81 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2019/09 | 34.25 | 33.3 | 35.65 | 33.25 | -0.95 | -2.77 | (1) | 膽固醇磷酸鹽結合劑 | 1.47 | 54.5 | +35.3 | +16.2 | 8.31 | 40.8 | -25.1 | | (2) | 維他命D衍生物 | 0.527 | 19.5 | +3.73 | +530.2 | 3.98 | 19.5 | +50.4 | | (3) | 中樞神經系統用藥 | 0.256 | 9.49 | +12.9 | -36.7 | 1.6 | 7.85 | +31.8 | | (4) | 呼吸系統用藥 | 0.213 | 7.89 | - | +458.1 | - | - | - | | (5) | 抗生素 | 0.0882 | 3.27 | -5.63 | - | - | - | - | | (6) | 消炎止痛劑 | 0.0704 | 2.61 | -67 | +5626.8 | 1.09 | 5.38 | +160.7 | | (7) | 抗癌活性成份 | 0.0283 | 1.05 | -88.8 | -31.7 | 1.12 | 5.51 | +105.4 | | (8) | 紫外線吸收劑 | 0.0254 | 0.94 | - | -63.8 | - | - | - | | (9) | 勞務 | 0.0094 | 0.35 | -90.8 | -95.1 | 0.612 | 3.01 | -19.3 | | (10) | 免疫調節劑 | 0.0009 | 0.03 | -91 | -99.3 | - | - | - | | 其他 | 其他 | 0.0844 | 3.13 | -38.8 | -6.59 | 0.659 | 3.24 | +21.9 | | 減 | 銷貨退回及折讓 | 0.0748 | -2.77 | -52.9 | +320.7 | 0.486 | -2.39 | +135.4 | | 合計 | 業務營收淨額 | 2.7 | 100 | +9.07 | +17.2 | 20.35 | 100 | +2.24 | | 2019/08 | 38.05 | 34.25 | 38.2 | 32.5 | -3.95 | -10.34 | (1) | 膽固醇磷酸鹽結合劑 | 1.09 | 43.9 | +4.6 | -30.8 | 6.84 | 38.7 | -30.4 | | (2) | 維他命D衍生物 | 0.508 | 20.6 | +102.2 | +762.5 | 3.45 | 19.5 | +34.8 | | (3) | 抗癌活性成份 | 0.253 | 10.2 | +38.7 | +531.9 | 1.09 | 6.19 | +116.6 | | (4) | 中樞神經系統用藥 | 0.227 | 9.17 | -42.7 | +2068.1 | 1.34 | 7.6 | +66.1 | | (5) | 消炎止痛劑 | 0.213 | 8.62 | +15.6 | +120.9 | 1.02 | 5.8 | +144.7 | | (6) | 勞務 | 0.103 | 4.15 | -7.69 | +3.88 | 0.602 | 3.41 | +6.21 | | (7) | 抗生素 | 0.0935 | 3.78 | +0.56 | - | - | - | - | | (8) | 免疫調節劑 | 0.0103 | 0.42 | -39.6 | -73.2 | - | - | - | | 其他 | 其他 | 0.138 | 5.58 | -28.4 | +134.3 | 0.574 | 3.25 | +27.7 | | 減 | 銷貨退回及折讓 | 0.159 | -6.42 | +72086.4 | +210.5 | 0.412 | -2.33 | +118 | | 合計 | 業務營收淨額 | 2.47 | 100 | -9.29 | +7.45 | 17.65 | 100 | +0.29 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2019/07 | 38.2 | 38.2 | 39.7 | 38.05 | +0.35 | +0.92 | (1) | 膽固醇磷酸鹽結合劑 | 1.04 | 38.1 | +37.8 | -20.9 | 5.75 | 37.9 | -30.4 | | (2) | 中樞神經系統用藥 | 0.396 | 14.5 | +1040.4 | +575.3 | 1.11 | 7.34 | +39.8 | | (3) | 維他命D衍生物 | 0.251 | 9.22 | -55.1 | -22 | 2.94 | 19.4 | +17.6 | | (4) | 呼吸系統用藥 | 0.224 | 8.23 | +320.2 | +40.1 | 0.754 | 4.96 | -17.4 | | (5) | 消炎止痛劑 | 0.184 | 6.77 | +43.3 | +594.1 | 0.811 | 5.34 | +151.8 | | (6) | 抗癌活性成份 | 0.183 | 6.7 | +41.4 | +294.4 | 0.84 | 5.53 | +80.8 | | (7) | 勞務 | 0.111 | 4.08 | +36.5 | +190.3 | 0.5 | 3.29 | +6.7 | | (8) | 抗生素 | 0.093 | 3.41 | - | - | - | - | - | | (9) | 紫外線吸收劑 | 0.0359 | 1.32 | -41.8 | +2060.2 | 1.4 | 9.22 | - | | (10) | 免疫調節劑 | 0.0171 | 0.63 | - | -84.3 | - | - | - | | 其他 | 其他 | 0.193 | 7.07 | +7699.6 | +7.36 | 0.436 | 2.87 | +11.6 | | 減 | 銷貨退回及折讓 | 0.0002 | -0.01 | - | -97.2 | 0.253 | -1.67 | +83.6 | | 合計 | 業務營收淨額 | 2.73 | 100 | +51.1 | +21.4 | 15.18 | 100 | -0.79 | | 2019/06 | 38 | 37.85 | 39 | 36.95 | -0.1 | -0.26 | (1) | 膽固醇磷酸鹽結合劑 | 0.753 | 41.8 | +20.2 | -46 | 4.71 | 37.8 | -32.2 | | (2) | 維他命D衍生物 | 0.56 | 31 | +29.7 | -17.6 | 2.69 | 21.6 | +23.5 | | (3) | 抗癌活性成份 | 0.129 | 7.16 | +79.6 | +440.9 | 0.657 | 5.28 | +57.2 | | (4) | 消炎止痛劑 | 0.129 | 7.13 | -16.3 | +616.7 | 0.627 | 5.03 | +112 | | (5) | 勞務 | 0.0814 | 4.51 | +208.8 | +30 | 0.389 | 3.12 | -9.63 | | (6) | 紫外線吸收劑 | 0.0616 | 3.41 | -70.8 | - | 1.36 | 11 | - | | (7) | 呼吸系統用藥 | 0.0534 | 2.96 | -60.7 | -76.9 | 0.529 | 4.25 | -29.6 | | (8) | 中樞神經系統用藥 | 0.0347 | 1.92 | -10 | -67.4 | 0.719 | 5.77 | -2.62 | | 其他 | 其他 | 0.0025 | 0.14 | -94.8 | -96.8 | 0.244 | 1.96 | +15.2 | | 減 | 銷貨退回及折讓 | 0 | 0 | -100 | - | 0.253 | -2.03 | +94.4 | | 合計 | 業務營收淨額 | 1.8 | 100 | -8.75 | -31.4 | 12.46 | 100 | -4.6 | | 月別 | 當月股價 | 項目 | 產品/業務 | 單月營收 | 累計營收 | | 開盤 | 收盤 | 最高 | 最低 | 漲跌
(元) | 漲跌
(%) | 營收
(億) | 佔比
(%) | 月增
(%) | 年增
(%) | 營收
(億) | 佔比
(%) | 年增
(%) | | 2019/05 | 41.45 | 37.95 | 42.05 | 36.65 | -3.5 | -8.44 | (1) | 膽固醇磷酸鹽結合劑 | 0.627 | 31.7 | -21.5 | -54.5 | 3.96 | 37.2 | -28.7 | | (2) | 維他命D衍生物 | 0.431 | 21.8 | -14.2 | +186.2 | 2.13 | 20 | +42 | | (3) | 免疫調節劑 | 0.211 | 10.7 | +175.3 | +82.6 | 0.444 | 4.17 | +20.9 | | (4) | 紫外線吸收劑 | 0.211 | 10.7 | -32.7 | -10.8 | 1.3 | 12.2 | +62.3 | | (5) | 消炎止痛劑 | 0.154 | 7.78 | +18.2 | +1033.2 | 0.498 | 4.68 | +79.4 | | (6) | 呼吸系統用藥 | 0.136 | 6.88 | +39.5 | +12.6 | 0.476 | 4.47 | -8.73 | | (7) | 抗癌活性成份 | 0.0719 | 3.64 | +13.2 | -60.5 | 0.528 | 4.96 | +33.9 | | (8) | 中樞神經系統用藥 | 0.0386 | 1.95 | -14.7 | -54.9 | 0.685 | 6.43 | +8.27 | | (9) | 勞務 | 0.0264 | 1.33 | -68.1 | +86.6 | 0.307 | 2.89 | -16.4 | | (10) | 抗生素 | 0.0244 | 1.23 | - | - | - | - | - | | 其他 | 其他 | 0.0477 | 2.41 | -10 | +2148.6 | 0.241 | 2.26 | +80.8 | | 減 | 銷貨退回及折讓 | 0.0015 | -0.07 | -67.8 | - | 0.253 | -2.37 | +94.4 | | 合計 | 業務營收淨額 | 1.98 | 100 | -8.4 | -13.9 | 10.65 | 100 | +2.18 |
|
